Kushner. Obesidad_1ed

78 Obesidad. Evaluación y tratamiento en atención primaria

69. Steele B, Cheryll T, Henley J, Massetti G, Galuska D. Vital signs: trends in incidence of cancers associated with over- weight and obesity – United States, 2005-2014. MMWR Morb Mortal Wkly Rep . 2017;66(39):1052-1058. 70. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol . 2011;29:415-445. doi:10.1146/ annurev-immunol-031210-101322 71. Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Canc . 2006;118(7):1591-1602. doi:10.1002/ijc.21683 72. Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology . 2018;67(1):358-380. doi:10.1002/hep.29086 73. Stroud A, Dewey E, Husian FA. Association between weight loss and serum biomarkers with risk of incident cancer in the Longitudinal Assessment of Bariatric Surgery cohort. Surg Obes Relat Dis . 2019;16:1086-1094. 74. Keum N, Greenwood DC, Lee DH, et al. Adult weight gain and adiposity-related cancers: a dose-response meta- analysis of prospective observational studies. J Natl Cancer Inst . 2015;107(2):djv088. doi:10.1093/jnci/djv088 75. Griggs JJ, Mangu PB, Anderson H, et al. Appropriate chemotherapy dosing for obese adult patients with

cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol . 2012;30(13):1553-1561. doi:10.1200/JCO.2011.39.9436 76. Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab . 2015;100(2):342-362. doi:10.1210/jc.2014-3415 77. Maurer DM, Raymond TJ, Davis BN. Depression: screen- ing and diagnosis. Am Fam Physician . 2018;98(8):508-515. 78. Igel LI, Kumar RB, Saunders KH, Aronne LJ. Practical use of pharmacotherapy for obesity. Gastroenterology . 2017;152(7):1765-1779. doi:10.1053/j.gastro.2016.12.049 79. Brownley KA, Berkman ND, Peat CM, Lohr KN, Bulik CM. Binge-eating disorder in adults. Ann Intern Med . 2017;166(3):231-232. doi:10.7326/L16-0621 80. Gallant AR, Lundgren J, Drapeau V. The night-eating syndrome and obesity. Obes Rev . 2012;13(6):528-536. doi:10.1111/j.1467-789X.2011.00975.x 81. O’Reardon JP, Allison KC, Martino NS, Lundgren JD, Heo M, Stunkard AJ. A randomized, placebo-controlled trial of sertraline in the treatment of night eating syn- drome. Am J Psychiatr . 2006;163(5):893-898. doi:10.1176/ ajp.2006.163.5.893

SAMPLE